pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
908
stories
7d
BMS welcomes new multiple myeloma drug as generics batter current portfolio
biospace
7d
Opinion: MAHA and insurance companies both want to treat human bodies like cars
stat
8d
New Taiho, Cullinan data heats up lung cancer drug battle
biopharma dive
8d
Karyopharm has a month left to salvage its cancer expansion plans
endpoints
8d
Taiho and Cullinan’s zipalertinib clears Phase 3, teeing up first-line competition
biospace
8d
Chutes & Ladders—Former Legend CEO lands at K2
fiercebiotech
8d
Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M
biospace
8d
Taiho, Cullinan's lung cancer drug passes Phase 3 test, lining up Rybrevant contest
endpoints
8d
STAT+: Neurocrine Biosciences and the delicate balance of benefit and risk
stat
8d
PDS halts work on phase 3 cancer therapy to focus on colorectal contender
fiercebiotech
8d
STAT+: As young people increasingly get cancer, new fertility options are changing their futures
stat
8d
Opinion: How to disrupt the health misinformation business model
stat
8d
STAT+: What patients actually think about ‘minimally invasive’ brain implants
stat
8d
Behind the bell: Gearing up to go public
biospace
8d
Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goal
fiercebiotech
8d
Zealand sells its rights to Takeda’s blood cancer drug for $100M ahead of FDA approval decision
fiercebiotech
9d
Recon: FDA grants Concerta generic withdrawal hearing; Ivonescimab wins first-line NSCLC nod in China
raps
9d
Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says
stat
9d
Vaping and cannabis hit record highs among young adults in 2025: Survey
stat
9d
Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill
fiercebiotech
9d
STAT+: Cancer patients face longer wait times to begin treatment, according to new study
stat
9d
AI clinical monitoring agent can deliver up to 82 times the ROI in oncology: report
fiercebiotech
9d
Boulevard starts up with $65M to pursue targeted autoimmune drugs
biopharma dive
9d
Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight
biospace
9d
Opinion: Climate change is making people with chronic illness even sicker
stat
9d
With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development
biospace
10d
CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaques
fiercebiotech
10d
Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs
biopharma dive
10d
How we know that splitting up the MMR vaccine could be dangerous
stat
10d
FDA rejects ITM Isotope’s radiopharma therapy over manufacturing issues
biospace
← prev
page 4 of 31
next →
